Naveenchandra Suryadevara
Overview
Explore the profile of Naveenchandra Suryadevara including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
38
Citations
3410
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jamieson P, Shen X, Abu-Shmais A, Wasdin P, Janowska K, Edwards R, et al.
bioRxiv
. 2025 Feb;
PMID: 39896680
HIV-1 continues to pose a significant global health challenge, requiring ongoing research into effective prevention and treatment strategies. Understanding the B cell repertoire that can be engaged upon vaccination in...
2.
Suryadevara N, Kose N, Bangaru S, Binshtein E, Munt J, Martinez D, et al.
J Clin Invest
. 2024 Nov;
135(3).
PMID: 39589795
The function of the spike protein N terminal domain (NTD) in coronavirus (CoV) infections is poorly understood. However, some rare antibodies that target the SARS-CoV-2 NTD potently neutralize the virus....
3.
Cabel C, Guzman B, Alizadeh E, Li S, Holberg C, Wichaidit C, et al.
bioRxiv
. 2024 Oct;
PMID: 39416139
The sudden rise of the SARS-CoV-2 virus and the delay in the development of effective therapeutics to mitigate it made evident a need for ways to screen for compounds that...
4.
Johnson N, Wall S, Kramer K, Holt C, Periasamy S, Richardson S, et al.
Structure
. 2024 Sep;
32(11):1893-1909.e11.
PMID: 39326419
The continued emergence of deadly human coronaviruses from animal reservoirs highlights the need for pan-coronavirus interventions for effective pandemic preparedness. Here, using linking B cell receptor to antigen specificity through...
5.
Suryadevara N, Otrelo-Cardoso A, Kose N, Hu Y, Binshtein E, Wolters R, et al.
Nat Microbiol
. 2024 Jun;
9(8):2128-2143.
PMID: 38858594
Human parainfluenza virus type 3 (hPIV3) is a respiratory pathogen that can cause severe disease in older people and infants. Currently, vaccines against hPIV3 are in clinical trials but none...
6.
Johnson N, Wall S, Kramer K, Holt C, Periasamy S, Richardson S, et al.
bioRxiv
. 2024 Jan;
PMID: 38293237
Three coronaviruses have spilled over from animal reservoirs into the human population and caused deadly epidemics or pandemics. The continued emergence of coronaviruses highlights the need for pan-coronavirus interventions for...
7.
Wall S, Suryadevara N, Kim C, Shiakolas A, Holt C, Irbe E, et al.
Cell Rep Med
. 2023 Nov;
4(11):101267.
PMID: 37935199
From the beginning of the COVID-19 pandemic, children have exhibited different susceptibility to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, reinfection, and disease compared with adults. Motivated by the...
8.
Wen X, Suryadevara N, Kose N, Liu J, Zhan X, Handal L, et al.
Cell Host Microbe
. 2023 Jul;
31(8):1288-1300.e6.
PMID: 37516111
Respiratory syncytial virus (RSV) and human metapneumovirus (hMPV) infections pose a significant health burden. Using pre-fusion conformation fusion (F) proteins, we isolated a panel of anti-F antibodies from a human...
9.
Suryadevara N, Kumar A, Ye X, Rogers M, Williams J, Wilson J, et al.
Sci Rep
. 2022 Nov;
12(1):19101.
PMID: 36351985
Natural infection as well as vaccination with live or attenuated viruses elicit tissue resident, CD8 memory T cell (Trm) response. Trm cells so elicited act quickly upon reencounter with the...
10.
Kramer K, Wilfong E, Voss K, Barone S, Shiakolas A, Raju N, et al.
Nat Commun
. 2022 Jun;
13(1):3466.
PMID: 35710908
RNA-based vaccines against SARS-CoV-2 have proven critical to limiting COVID-19 disease severity and spread. Cellular mechanisms driving antigen-specific responses to these vaccines, however, remain uncertain. Here we identify and characterize...